Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$23.53+0.06 (+0.26%)
Close on Nov 17, 2026Market cap $3.65BP/E –Yield –
Zai Lab operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zai Lab's operating cash flow for the twelve months ending Jun 30, 2026 was -$133.38M. For fiscal 2025 it was -$150.79M. The highest annual figure on record is -$11.46M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$150.79M | – |
| FY2024 | Dec 31, 2024 | -$214.87M | – |
| FY2023 | Dec 31, 2023 | -$198.18M | – |
| FY2022 | Dec 31, 2022 | -$367.64M | – |
| FY2021 | Dec 31, 2021 | -$549.23M | – |
| FY2020 | Dec 31, 2020 | -$216.06M | – |
| FY2019 | Dec 31, 2019 | -$191.01M | – |
| FY2018 | Dec 31, 2018 | -$97.54M | – |
| FY2017 | Dec 31, 2017 | -$32.37M | – |
| FY2016 | Dec 31, 2016 | -$32.16M | – |
| FY2015 | Dec 31, 2015 | -$11.46M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$63.41M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$32.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$31.02M | – |
| Q1 FY2025 | Mar 31, 2025 | -$61.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$55.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$26.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$42.17M | – |
| Q1 FY2024 | Mar 31, 2024 | -$90.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.92M | – |
| Q3 FY2023 | Sep 30, 2023 | -$55.27M | – |
| Q2 FY2023 | Jun 30, 2023 | -$58.70M | – |
| Q1 FY2023 | Mar 31, 2023 | -$69.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$109.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$126.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$44.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$87.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$152.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$160.89M | – |
| Q2 FY2021 | Jun 30, 2021 | -$65.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$169.50M | – |
| Q4 FY2020 | Dec 31, 2020 | -$44.34M | – |
| Q3 FY2020 | Sep 30, 2020 | -$79.40M | – |
| Q2 FY2020 | Jun 30, 2020 | -$52.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$39.84M | – |
| Q4 FY2019 | Dec 31, 2019 | -$40.02M | – |
| Q3 FY2019 | Sep 30, 2019 | -$67.81M | – |
| Q4 FY2018 | Dec 31, 2018 | -$44.63M | – |
See a number that looks wrong?